MedCity News July 23, 2025
Adam Binks

Leaders in pharma’s AI age won’t be remembered for moving the fastest, but for earning and keeping trust along the way. Privacy will determine which companies pull ahead and which fall behind, making it one of the industry’s biggest tests.

AI has quickly been moving through the pharmaceutical industry, where professionals are seeing clear value – from shortening the drug development timeline to matching patients to more relevant trials. But while innovation accelerates, consumer trust in the technology is lagging behind.

Pew found that 3 in 5 Americans would be uncomfortable with their healthcare providers relying on AI, and another 37% believe AI use in healthcare would worsen the security of patient records. The challenge isn’t a lack of...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Privacy / Security, Technology
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat

Share Article